MELISSA at the Dutch Endocrine Meeting 2026
From 5 to 6 February the Dutch Endocrine Meeting 2026 (DEM) brought together healthcare professionals from across the board – internists, pediatricians, clinical chemists, nurses, and many others involved in conditions ranging from bone health to diabetes to endocrine cancers. The meeting offered a vibrant setting for exchanging insights and strengthening interdisciplinary connections. The MELISSA consortium, represented by Cassy Dingena, was invited to present its clinical trial in two formats. First, a poster session provided an informal space to introduce the clinical trial and engage directly with those interested. On the second day, the trial was highlighted during a clinical session, where information and experience on running clinical trials in the Dutch endocrine community was shared. Both moments offered a valuable opportunity to raise awareness, encourage participation, and increase visibility for the MELISSA trial.
About DEM
DEM is hosted by the Dutch Society for Endocrinology, the national organisation representing everyone working in the field of endocrinology. The society’s mission is to strengthen care for people with endocrine and metabolic disorders by advancing knowledge and fostering collaboration.
